Last reviewed · How we verify
Anthelios Sx (OCTOCRYLENE)
At a glance
| Generic name | OCTOCRYLENE |
|---|---|
| Sponsor | Loreal Usa |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 2006 |
Approved indications
Common side effects
Key clinical trials
- Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen (PHASE1)
- Assessment of the Human Systemic Absorption of Sunscreen Ingredients (PHASE1)
- Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma (PHASE4)
- Multi-Centre European Photopatch Test Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anthelios Sx CI brief — competitive landscape report
- Anthelios Sx updates RSS · CI watch RSS